Results 251 to 260 of about 40,821 (327)

The dual endothelin A and angiotensin II type 1 receptor antagonist sparsentan (FILSPARI®) exhibits a safe nonclinical male fertility toxicity profile

Patricia W. Bedard, Francesca Pretto, Sima Patel, Celia Jenkinson, Tacey White, Donald E. Kohan   +5 more
openalex   +1 more source

Current Knowledge About Aprocitentan in Hypertension. [PDF]

Int J Mol Sci
Bank-Mikkelsen EM, Grimm D, Wehland M.
europepmc   +1 more source

RES-1214-1 and -2, Novel Non-peptidic Endothelin Type A Receptor Antagonists Produced by Pestalotiopsis sp.

, 1995
T. Ogawa, Katsuhiko Ando, YUMIKO AOTANI, Katsumi Shinoda, Takeo Tanaka, Em TSUKUDA, Mayumi Yoshida, Yuzuru Matsuda   +7 more
openalex   +2 more sources

The Involvement of the Peptidergic Systems in Breast Cancer Development. [PDF]

Cancers (Basel)
Sánchez ML, Robinson P, Italia Z, Hoang T, Muñoz M, Coveñas R.   +5 more
europepmc   +1 more source

Successful use of methylene blue for severe vasoplegia in a patient with partially-treated portopulmonary hypertension with atrial septal defect undergoing liver transplantation: a case report. [PDF]

BMC Anesthesiol
Ishihara T, Kawamura G, Nagano M, Azuma S, Uchida K, Kariya T.   +5 more
europepmc   +1 more source

Do we need endothelin antagonists? [PDF]

, 2017
Lüscher, Thomas F.
core  

Generating CAR-macrophages to target endothelin B receptor-positive tumors. [PDF]

Cancer Immunol Immunother
Lherminier C, Costa N, Herbet A, Hautière M, Mabondzo A, Martinet J, Boquet D.   +6 more
europepmc   +1 more source

Successful Clazosentan Therapy for Subarachnoid Hemorrhage after Coil Embolization of Ruptured Posterior Cerebral Artery Aneurysm in a Patient with Moyamoya Disease: A Case Report. [PDF]

NMC Case Rep J
Uchino H, Sugiyama T, Hokari M, Yamaguchi Y, Osanai T, Fujimura M.   +5 more
europepmc   +1 more source

Endothelin-1 Stimulates the Growth of Visceral and Subcutaneous Human Preadipocytes through Similar and Alternative Signaling Pathways via Type A and Type B Endothelin Receptors: Potential Implications for Therapeutic Strategies for Obesity and Metabolic Disorders. [PDF]

Int J Med Sci
Siao AC, Kao YH, Kuo CC, Shyu HY, Kuo YC, Chiang WF, Wu KA, Shih LJ, Hsiao PJ.   +8 more
europepmc   +1 more source

Real-World Adherence and Persistence of Upfront Therapy in Patients with Pulmonary Arterial Hypertension in the United States. [PDF]

Pulm Ther
De Marco T, Paoli CJ, Croteau NS, Tang F, Farber HW.   +4 more
europepmc   +1 more source